Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

202.00
-2.5888-1.27%
Pre-market: 203.891.89+0.94%06:02 EDT
Volume:1.92M
Turnover:387.21M
Market Cap:10.29B
PE:32.00
High:204.18
Open:203.82
Low:200.52
Close:204.59
52wk High:217.12
52wk Low:138.79
Shares:50.95M
Float Shares:50.95M
Volume Ratio:1.14
T/O Rate:3.76%
Dividend:0.40
Dividend Rate:0.20%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.26
PE(LYR):5.72

Loading ...

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Reuters
·
6 hours ago

Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure

TIPRANKS
·
7 hours ago

Cambium Bio Plans New Share Placement to Bolster Capital Base

TIPRANKS
·
8 hours ago

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Reuters
·
13 hours ago

Sector Update: Healthcare

MT Newswires Live
·
17 hours ago

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU
·
18 hours ago

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live
·
Yesterday

Gilead announces agreement with PAHO for lenacapavir access

TIPRANKS
·
Yesterday

Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir

THOMSON REUTERS
·
Yesterday

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS
·
Yesterday

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS
·
Yesterday

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Reuters
·
Yesterday

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS
·
Yesterday

Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call

THOMSON REUTERS
·
Yesterday

Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call

THOMSON REUTERS
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17

Reuters
·
Yesterday

Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Dow Jones
·
Yesterday

Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness

TIPRANKS
·
Yesterday

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Yesterday